Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Texas Instruments Incorporated

TXN

NEUTRAL

May 23, 2026

Research Conclusion

HOLD at ~$312. ACCUMULATE at $250–280. BUY below $230. TRIM above $340. Texas Instruments is a Tier 1 analog semiconductor compounder with a wide moat, but the investment thesis is fully priced at current levels. At $312, the stock trades 15% above the consolidated intrinsic range ($230–$305) and within 3% of the bull-case ceiling. The FCF/share inflection from the completed capex super-cycle and industrial recovery are real and already priced in. Expected return is -10% (excl. dividend) or -8% (incl. 1.7% yield) over 12 months. The genuine accumulation zone is $250–$280 where FCF yield (FY28E mid-cycle) exceeds 4%, P/E (FY26E base) falls within historical mid-cycle range, and bull-case upside re-opens to 20%+.

Company Overview & Moat Assessment

Texas Instruments is the world's largest analog semiconductor company and third-largest US-based semiconductor company. Founded in 1930 in Dallas, Texas, TI employs ~33,000 and operates two businesses: Analog ($14.0B, 79% of revenue) covering power management and signal chain across 80,000+ products, and Embedded Processing ($2.7B, 15%) with MCUs and automotive processors. End-market exposure: Industrial 33%, Automotive 33%, Personal Electronics 21%, Data Center 9%, Communications 3%. Manufacturing footprint comprises seven US fabs built on 300mm wafers delivering ~40% unit cost advantage vs. 200mm peers. FY2025 results: $17.68B revenue (+13% YoY), 57.0% gross margin, $5.45 diluted EPS, $2.6B FCF. Silicon Labs acquisition ($7.5B, announced Feb 2026) expected to close 1H 2027. Company has 21+ consecutive years of dividend growth.

▲ Bull Case

  • FCF/share inflection is real and front-loaded—$8+/share FY26E, $11/share by FY28E mid-cycle. The $39B 2021–2025 capex super-cycle is 83% complete; FY26 capex guidance of $2–3B (down from $4.55B FY25) signals roll-off into productive revenue. FCF/share roughly doubles year-by-year until depreciation catches up. Mid-cycle FCF/share of $10 supports a 4% yield at $250 (the floor) and a 32% return to that level if materializes.
  • 300mm cost advantage delivers structural gross margin expansion from 57% (FY25 trough) to 64% (mid-cycle). Each 300mm wafer-built chip costs ~40% less than 200mm; TXN's 80,000-product catalog amplifies the cost advantage across every product. Sherman SM1 began production Dec 2025; RFAB2 ramping; LFAB1 utilization improving. Even conservative bridge to 64% gross margin (vs. FY22 peak 68%) adds ~$3B of run-rate operating income.
  • Industrial + Automotive recovery is multi-year, not a head-fake. Q1 FY26 delivered first broad-based sequential growth across all sectors, geographies, and customer sizes in 2 years. Industrial first sequential positive in 2 years; Data Center revenue +90% YoY; all customer sizes growing. Capacity replenishment cycle in industrial is typically 3–5 years. EV content per vehicle continues to grow even with flat volumes. Silicon Labs adds wireless connectivity and IoT strategic moat in Embedded Processing.

▼ Bear Case

  • Goldman Sachs fixed-cost-absorption bear is the most underweighted risk. TXN's $39B 2021–2025 capex built capacity for ~$28–32B revenue at 85% utilization; FY25 revenue of $17.68B implies <60% utilization. If industrial recovery proceeds at only moderate pace (or false-starts) and Chinese demand erodes 2.5%/yr, FY30E revenue lands at ~$22B vs. base case $26.4B. Modeled bear: gross margin stalls at 60%, FCF/share lands at $7.50 (vs. base $11.40), fair value compresses to $195 (-38%).
  • Chinese analog competition has likely permanently compressed the through-cycle gross margin ceiling. TXN's historical peak gross margin of ~68% (FY22) was achieved before Chinese state-backed analog (SG Micro, 3Peak, Will Semi, Silergy) reached credible production scale. Their gradual share gains in interface, gate-driver, and standard power management are structural, not cyclical. The through-cycle gross margin ceiling has likely shifted to 64–65%, with bear case stalling at 60%.
  • Multiple compression is the single largest mark-to-mean risk. TXN trades at 39x FY2026E consensus EPS—the 95th percentile of its 10-year history (median ~24x). Reversion to 10-year mean (24x) on FY27E base EPS $8.80 = $211 (-32%). This risk is independent of cycle: even if revenue and margins hit base case, normal-cycle P/E multiple compression takes the stock down -32%.
Primary Debate on Wall Street

The primary Wall Street debate centers on whether TXN's premium-to-peers multiple is defensible as gross margin recovers, or whether Chinese analog competition has structurally lowered the through-cycle margin ceiling. Bulls argue TXN's 300mm scale, 80,000-product catalog, direct customer relationships, manufacturing self-sufficiency, and CHIPS Act alignment create defensible premium. Bears counter that both TXN and ADI face Chinese analog threats; the threat hits TXN's higher-volume standard-grade products more; ADI's AI data center positioning is structurally stronger; TXN's capex cycle leaves higher embedded depreciation; and the FY22 peak 68% GM was achieved before structural Chinese pressure. Our reading: The premium is stable, not widening. TXN deserves modest premium on higher FCF margin and cleaner cash conversion, but the case for premium widening has weakened. Current 17% P/E premium (39x vs. ADI's 30x) is at the top of historical range. The market is paying for the premium to stay at the top of its band—a posture difficult to sustain.

Top Catalysts
  • Q2 FY2026 earnings (July 2026): Industrial sequential growth continuation; Data Center sustenance; false-start would trigger re-trough warning.
  • Q3 FY2026 earnings (October 2026): FY27 capex guide ≤$2.2B and FCF/share trajectory toward $10+; capex ≥$3.0B would activate Goldman bear thesis.
  • Silicon Labs deal close (1H 2027): Expected close on schedule with >$150M FY28 synergy articulated; delay or integration drag challenges capital allocation credibility.
  • 4Q 2026 earnings + FY27 guide (January 2027): Revenue guide >$23B and GM 62%+ confirm bull trajectory; flat revenue + GM 60% shifts verdict toward bear.
  • Sherman SM2 + RFAB2 ramp milestones (2026–2027): Production on-time and >85% nameplate utilization confirm productivity; idle capacity signals margin drag.
  • China tariff resolution (2026–2027): Standard exemption framework favorable; expanded scope on Interface/Gate Driver impacts ~11.4% of revenue.
  • TI Capital Markets Day (periodic): Reaffirmation of FCF/share trajectory and mid-cycle GM 64%+ critical for confidence; lowered aspirations triggers multiple compression.
Top Risks
  • Multiple compression (39x → 24x mean reversion): HIGH (60–70%), -25–35% impact. Largest single risk independent of cycle fundamentals.
  • Chinese analog competition + tariff disruption: MEDIUM-HIGH (50–60%), -8–15% impact from structural multi-year erosion of ~11.4% of revenue.
  • Fixed-cost absorption (Goldman bear): MEDIUM (35–45%), -20–30% impact if revenue growth stalls with embedded depreciation drag.
  • Industrial cycle stall or re-trough: MEDIUM (30–40%), -15–25% impact; Q1 FY26 recovery is signal but not proof of durability.
  • Auto EV demand softness: MEDIUM (35–45%), -5–10% revenue impact; 33% of revenue exposed though EV content growth provides offset.
  • Silicon Labs integration drag: LOW-MEDIUM (20–30%), -3–5% impact from manageable-scale acquisition.
  • CHIPS Act receivable disruption (political): LOW (15–25%), -2–4% impact from $3.35B receivables exposed to political volatility.
  • Capital allocation discipline failure: LOW-MEDIUM (25–35%), -5–10% FCF/share impact if capex restraint isn't maintained post-super-cycle.
  • Embedded Processing op margin recovery: MEDIUM (30–40%), -1–2% revenue and mix headwind from LFAB underutilization at 11.3% op margin.
  • Customer concentration (12% top customer): LOW (10–15%), -3–5% impact; relationship is long-tenured.

Full Memo Continues

5 more sections, locked

  • Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/TXN/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.